{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:42:37Z","timestamp":1794120157061,"version":"4.8.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To review the pathogenesis of inclusion body myositis (IBM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>IBM is an autoimmune disease. Multiple arms of the immune system are activated, but a direct attack on muscle fibers by highly differentiated T cells drives muscle destruction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Further understanding of the pathogenesis of IBM guides rational approaches to developing therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000752","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T14:22:59Z","timestamp":1600266179000},"page":"542-547","source":"Crossref","is-referenced-by-count":23,"title":["Pathogenesis of inclusion body myositis"],"prefix":"10.1097","volume":"32","author":[{"given":"Steven A.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410190203","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. III: immunoelectron microscopy aspects of cell-mediated muscle fiber injury","volume":"19","author":"Arahata","year":"1986","journal-title":"Ann Neurol"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.410230210","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. IV: cell-mediated cytotoxicity and muscle fiber necrosis","volume":"23","author":"Arahata","year":"1988","journal-title":"Ann Neurol"},{"issue":"(2)","key":"R5-20230829","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/mus.880181312","article-title":"Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses","author":"Arahata","year":"1995","journal-title":"Muscle Nerve Suppl"},{"key":"R6-20230829","first-page":"1586","article-title":"Sporadic inclusion body myositis and other rimmed vacuolar myopathies","volume":"25","author":"Weihl","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000265398.77681.09","article-title":"T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis","volume":"69","author":"Salajegheh","year":"2007","journal-title":"Neurology"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ajpath.2011.05.055","article-title":"Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-gamma signaling cascade in attacked versus nonattacked myofibers","volume":"179","author":"Ivanidze","year":"2011","journal-title":"Am J Pathol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"e88788","DOI":"10.1371\/journal.pone.0088788","article-title":"Th1 response and systemic treg deficiency in inclusion body myositis","volume":"9","author":"Allenbach","year":"2014","journal-title":"PLoS One"},{"issue":"(Pt 5)","key":"R10-20230829","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/brain\/aww024","article-title":"Association of inclusion body myositis with T cell large granular lymphocytic leukaemia","volume":"139","author":"Greenberg","year":"2016","journal-title":"Brain"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/brain\/awz207","article-title":"Highly differentiated cytotoxic T cells in inclusion body myositis","volume":"142","author":"Greenberg","year":"2019","journal-title":"Brain"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2019.02.003","article-title":"CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis","volume":"18","author":"Dzangue-Tchoupou","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"e1193","DOI":"10.1212\/WNL.0000000000008128","article-title":"Identification of distinctive interferon gene signatures in different types of myositis","volume":"93","author":"Pinal-Fernandez","year":"2019","journal-title":"Neurology"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1073\/pnas.082545599","article-title":"Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle","volume":"99","author":"Sugarman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"331ra41","DOI":"10.1126\/scitranslmed.aad4583","article-title":"Targeting protein homeostasis in sporadic inclusion body myositis","volume":"8","author":"Ahmed","year":"2016","journal-title":"Sci Transl Med"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"R829","DOI":"10.1152\/ajpregu.00639.2007","article-title":"Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis","volume":"294","author":"Chen","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/iep.12048","article-title":"Primary over-expression of AbetaPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AbetaPP transgenic mouse","volume":"94","author":"Luo","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.nbd.2010.05.018","article-title":"Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle","volume":"39","author":"Beckett","year":"2010","journal-title":"Neurobiol Dis"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"20534","DOI":"10.1074\/jbc.M112.359588","article-title":"Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice","volume":"287","author":"Boncompagni","year":"2012","journal-title":"J Biol Chem"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"b2680","DOI":"10.1136\/bmj.b2680","article-title":"How citation distortions create unfounded authority: analysis of a citation network","volume":"339","author":"Greenberg","year":"2009","journal-title":"BMJ"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/brain\/awz229","article-title":"Inclusion body myositis: accumulation of evidence for its autoimmune origin","volume":"142","author":"Benveniste","year":"2019","journal-title":"Brain"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","article-title":"Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken","volume":"129","author":"Benveniste","year":"2015","journal-title":"Acta Neuropathol"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"92","DOI":"10.31138\/mjr.29.2.92","article-title":"Sjogren syndrome associated with inflammatory muscle diseases","volume":"29","author":"Migkos","year":"2018","journal-title":"Mediterr J Rheumatol"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","article-title":"Molecular profiles of inflammatory myopathies","volume":"59","author":"Greenberg","year":"2002","journal-title":"Neurology"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00002281-199711000-00007","article-title":"Cellular immune mechanisms in inflammatory myopathies","volume":"9","author":"Hohlfeld","year":"1997","journal-title":"Curr Opin Rheumatol"},{"issue":"(Pt 5)","key":"R26-20230829","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/brain\/aww053","article-title":"Cytotoxic T cells go awry in inclusion body myositis","volume":"139","author":"Hohlfeld","year":"2016","journal-title":"Brain"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-5728(97)00246-4","article-title":"T-cell heterogeneity in muscle lesions of inclusion body myositis","volume":"84","author":"Bender","year":"1998","journal-title":"J Neuroimmunol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1002\/art.27665","article-title":"Expanded T cell receptor Vbeta-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells","volume":"62","author":"Pandya","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"23002","DOI":"10.1038\/srep23002","article-title":"Effects of systemically administered hydrocortisone on the human immunome","volume":"6","author":"Olnes","year":"2016","journal-title":"Sci Rep"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13075-016-0974-5","article-title":"Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis","volume":"18","author":"Pandya","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.1995.tb03587.x","article-title":"Local T-cell proliferation and differentiation in inflammatory myopathies","volume":"41","author":"Lindberg","year":"1995","journal-title":"Scand J Immunol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.56.3.323","article-title":"A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM","volume":"56","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"issue":"(Pt 6)","key":"R33-20230829","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","article-title":"Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis","volume":"132","author":"Dalakas","year":"2009","journal-title":"Brain"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2016.62","article-title":"The unfolded protein response in immunity and inflammation","volume":"16","author":"Grootjans","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11926-012-0247-5","article-title":"Endoplasmic reticulum stress in skeletal muscle homeostasis and disease","volume":"14","author":"Rayavarapu","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s12253-020-00799-y","article-title":"Autophagy, mitophagy and microRNA expression in chronic hepatitis C and autoimmune hepatitis","volume":"26","author":"Szekerczes","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jnen\/nlv023","article-title":"T-cell-mediated inflammatory myopathies in HIV-positive individuals: a histologic study of 19 cases","volume":"75","author":"Hiniker","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12772","article-title":"Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies","volume":"30","author":"Fischer","year":"2020","journal-title":"Brain Pathol"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.26608","article-title":"Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy","volume":"60","author":"Girolamo","year":"2019","journal-title":"Muscle Nerve"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1073\/pnas.1313654110","article-title":"Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation","volume":"110","author":"Jones","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2017.0676","article-title":"Interpreting lymphocyte reconstitution data from the pivotal phase 3 trials of alemtuzumab","volume":"74","author":"Baker","year":"2017","journal-title":"JAMA Neurol"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/01.WNL.0000071852.27182.C7","article-title":"Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study","volume":"61","author":"Lindberg","year":"2003","journal-title":"Neurology"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ajt.13092","article-title":"ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients","volume":"15","author":"Crepin","year":"2015","journal-title":"Am J Transplant"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.4049\/jimmunol.0903805","article-title":"Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice","volume":"186","author":"Wang","year":"2011","journal-title":"J Immunol"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"9213","DOI":"10.1073\/pnas.142166599","article-title":"A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification","volume":"99","author":"Pallafacchina","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"(Pt 7)","key":"R47-20230829","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1113\/jphysiol.2008.163816","article-title":"Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis","volume":"587","author":"Drummond","year":"2009","journal-title":"J Physiol"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/S0317167100036684","article-title":"Inclusion body myositis associated with systemic sarcoidosis","volume":"13","author":"Danon","year":"1986","journal-title":"Can J Neurol Sci"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jnnp.2009.190751","article-title":"Distal muscle involvement in granulomatous myositis can mimic inclusion body myositis","volume":"82","author":"Larue","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nmd.2018.10.007","article-title":"Myopathies featuring noncaseating granulomas: sarcoidosis, inclusion body myositis and an unfolding overlap","volume":"29","author":"Alhammad","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"e910","DOI":"10.1212\/WNL.0000000000008863","article-title":"Granulomatosis-associated myositis: high prevalence of sporadic inclusion body myositis","volume":"94","author":"Dieudonne","year":"2020","journal-title":"Neurology"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T03:14:18Z","timestamp":1693278858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000752","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}